These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23162979)

  • 1. Diabetes screening as part of a vascular disease risk management programme.
    Bartram S; Rigby D
    Community Pract; 2012 Oct; 85(10):24-7. PubMed ID: 23162979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
    Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
    Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial.
    Simmons RK; Echouffo-Tcheugui JB; Sharp SJ; Sargeant LA; Williams KM; Prevost AT; Kinmonth AL; Wareham NJ; Griffin SJ
    Lancet; 2012 Nov; 380(9855):1741-8. PubMed ID: 23040422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1c The Danish Inter99 study.
    Borg R; Vistisen D; Witte DR; Borch-Johnsen K
    Diabet Med; 2010 Aug; 27(8):906-10. PubMed ID: 20653748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for type 2 diabetes: a short report for the National Screening Committee.
    Waugh NR; Shyangdan D; Taylor-Phillips S; Suri G; Hall B
    Health Technol Assess; 2013 Aug; 17(35):1-90. PubMed ID: 23972041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence, detection, and epidemiological correlates of peripheral vascular disease: a comparison of diabetic and non-diabetic subjects in an English community.
    Walters DP; Gatling W; Mullee MA; Hill RD
    Diabet Med; 1992 Oct; 9(8):710-5. PubMed ID: 1395462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of glucometer and fasting blood glucose as screening tools for diabetes mellitus type 2 and glycated haemoglobin as clinical reference in rural community primary care settings of a middle income country.
    Muktabhant B; Sanchaisuriya P; Sarakarn P; Tawityanon W; Trakulwong M; Worawat S; Schelp FP
    BMC Public Health; 2012 May; 12():349. PubMed ID: 22583817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of glycated hemoglobin in screening and diagnosing type 2 diabetes mellitus in Chinese subjects.
    Yu Y; Ouyang XJ; Lou QL; Gu LB; Mo YZ; Ko GT; Chow CC; So WY; Ma R; Kong A; Brown N; Nan J; Chan J; Bian RW
    Korean J Intern Med; 2012 Mar; 27(1):41-6. PubMed ID: 22403498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidity and glycemic control in patients with type 2 diabetes.
    El-Kebbi IM; Ziemer DC; Cook CB; Miller CD; Gallina DL; Phillips LS
    Arch Intern Med; 2001 May; 161(10):1295-300. PubMed ID: 11371257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening programme for microvascular complications and hypertension in a community diabetic population.
    Higgs ER; Kelleher A; Simpson HC; Reckless JP
    Diabet Med; 1992 Jul; 9(6):550-6. PubMed ID: 1643804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for type 2 diabetes: literature review and economic modelling.
    Waugh N; Scotland G; McNamee P; Gillett M; Brennan A; Goyder E; Williams R; John A
    Health Technol Assess; 2007 May; 11(17):iii-iv, ix-xi, 1-125. PubMed ID: 17462167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the potential population impact of stepwise screening strategies for identifying and treating individuals at high risk of Type 2 diabetes: a modelling study.
    Chamnan P; Simmons RK; Khaw KT; Wareham NJ; Griffin SJ
    Diabet Med; 2012 Jul; 29(7):893-904. PubMed ID: 22340130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study.
    Wang W; Lee ET; Fabsitz R; Welty TK; Howard BV
    Diabetes Care; 2002 Aug; 25(8):1365-70. PubMed ID: 12145236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for type 2 diabetes. Lessons from the ADDITION-Europe study.
    van den Donk M; Sandbaek A; Borch-Johnsen K; Lauritzen T; Simmons RK; Wareham NJ; Griffin SJ; Davies MJ; Khunti K; Rutten GE
    Diabet Med; 2011 Nov; 28(11):1416-24. PubMed ID: 21679235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemoglobin A1c analysis in the management of patients with diabetes: from chaos to harmony.
    Berg AH; Sacks DB
    J Clin Pathol; 2008 Sep; 61(9):983-7. PubMed ID: 18755722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the relationships of the glucose tolerance test and the glycated haemoglobin assay with diabetic vascular disease in the community. The Islington Diabetes Survey.
    Jackson CA; Yudkin JS; Forrest RD
    Diabetes Res Clin Pract; 1992 Aug; 17(2):111-23. PubMed ID: 1425145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycemic control and microvascular complications among type 2 diabetes at primary care units.
    Mayurasakorn K; Somthip N; Caengow S; Chulkarat N; Wanichsuwan M
    J Med Assoc Thai; 2009 Aug; 92(8):1094-101. PubMed ID: 19694336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HbA1c screening for undiagnosed diabetes in New Zealand.
    Ellison TL; Elliott R; Moyes SA
    Diabetes Metab Res Rev; 2005; 21(1):65-70. PubMed ID: 15386815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a new scoring system for predicting the 5 year incidence of type 2 diabetes in Japan: the Toranomon Hospital Health Management Center Study 6 (TOPICS 6).
    Heianza Y; Arase Y; Hsieh SD; Saito K; Tsuji H; Kodama S; Tanaka S; Ohashi Y; Shimano H; Yamada N; Hara S; Sone H
    Diabetologia; 2012 Dec; 55(12):3213-23. PubMed ID: 22955996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in physical activity and modelled cardiovascular risk following diagnosis of diabetes: 1-year results from the ADDITION-Cambridge trial cohort.
    Barakat A; Williams KM; Prevost AT; Kinmonth AL; Wareham NJ; Griffin SJ; Simmons RK
    Diabet Med; 2013 Feb; 30(2):233-8. PubMed ID: 22913463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.